
### [MONDO:0020193](http://purl.obolibrary.org/obo/MONDO_0020193)
**Label:** secretory apparatus of the lacrimal system anomaly

**Subclasses:** [MONDO:0009131](http://purl.obolibrary.org/obo/MONDO_0009131) (Riley-Day syndrome), [MONDO:0010460](http://purl.obolibrary.org/obo/MONDO_0010460) (syndromic X-linked intellectual disability 17), [MONDO:0009279](http://purl.obolibrary.org/obo/MONDO_0009279) (triple-a syndrome), [MONDO:0007509](http://purl.obolibrary.org/obo/MONDO_0007509) (ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant), [MONDO:0001203](http://purl.obolibrary.org/obo/MONDO_0001203) (prolapse of lacrimal gland), [MONDO:0004812](http://purl.obolibrary.org/obo/MONDO_0004812) (acute dacryoadenitis), [MONDO:0001588](http://purl.obolibrary.org/obo/MONDO_0001588) (chronic lacrimal gland enlargement), [MONDO:0002475](http://purl.obolibrary.org/obo/MONDO_0002475) (lacrimal gland adenocarcinoma), [MONDO:0012806](http://purl.obolibrary.org/obo/MONDO_0012806) (ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant), [MONDO:0010585](http://purl.obolibrary.org/obo/MONDO_0010585) (X-linked hypohidrotic ectodermal dysplasia), [MONDO:0010293](http://purl.obolibrary.org/obo/MONDO_0010293) (hypohidrotic ectodermal dysplasia with immunodeficiency), [MONDO:0015884](http://purl.obolibrary.org/obo/MONDO_0015884) (autosomal dominant hypohidrotic ectodermal dysplasia), [MONDO:0010030](http://purl.obolibrary.org/obo/MONDO_0010030) (Sjogren syndrome), [MONDO:0016535](http://purl.obolibrary.org/obo/MONDO_0016535) (hypohidrotic ectodermal dysplasia), [MONDO:0013982](http://purl.obolibrary.org/obo/MONDO_0013982) (ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant), [MONDO:0013983](http://purl.obolibrary.org/obo/MONDO_0013983) (ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0009147](http://purl.obolibrary.org/obo/MONDO_0009147) (ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0021222](http://purl.obolibrary.org/obo/MONDO_0021222) (lacrimal gland neoplasm), [MONDO:0021488](http://purl.obolibrary.org/obo/MONDO_0021488) (benign neoplasm of lacrimal gland), [MONDO:0004804](http://purl.obolibrary.org/obo/MONDO_0004804) (dacryoadenitis), [MONDO:0002469](http://purl.obolibrary.org/obo/MONDO_0002469) (lacrimal gland carcinoma ex pleomorphic adenoma), [MONDO:0004800](http://purl.obolibrary.org/obo/MONDO_0004800) (chronic dacryoadenitis), [MONDO:0002464](http://purl.obolibrary.org/obo/MONDO_0002464) (lacrimal gland cancer), [MONDO:0002463](http://purl.obolibrary.org/obo/MONDO_0002463) (lacrimal gland carcinoma), [MONDO:0020194](http://purl.obolibrary.org/obo/MONDO_0020194) (congenital alacrima), [MONDO:0014219](http://purl.obolibrary.org/obo/MONDO_0014219) (alacrima, achalasia, and mental retardation syndrome), [MONDO:0011105](http://purl.obolibrary.org/obo/MONDO_0011105) (alacrima, congenital, autosomal recessive), [MONDO:0003492](http://purl.obolibrary.org/obo/MONDO_0003492) (lacrimal gland squamous cell carcinoma), [MONDO:0006262](http://purl.obolibrary.org/obo/MONDO_0006262) (lacrimal gland adenoid cystic carcinoma), [MONDO:0016619](http://purl.obolibrary.org/obo/MONDO_0016619) (autosomal recessive hypohidrotic ectodermal dysplasia), [MONDO:0007075](http://purl.obolibrary.org/obo/MONDO_0007075) (alacrima, congenital, autosomal dominant), [MONDO:0003092](http://purl.obolibrary.org/obo/MONDO_0003092) (lacrimal gland mucoepidermoid carcinoma), [MONDO:0019627](http://purl.obolibrary.org/obo/MONDO_0019627) (isolated congenital alacrima), 

**Mapped go classes:** [GO:0007252](http://purl.obolibrary.org/obo/GO_0007252) (I-kappaB phosphorylation), [GO:0007253](http://purl.obolibrary.org/obo/GO_0007253) (cytoplasmic sequestering of NF-kappaB), [GO:0007250](http://purl.obolibrary.org/obo/GO_0007250) (activation of NF-kappaB-inducing kinase activity), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0005123](http://purl.obolibrary.org/obo/GO_0005123) (death receptor binding), [GO:0002098](http://purl.obolibrary.org/obo/GO_0002098) (tRNA wobble uridine modification), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005643](http://purl.obolibrary.org/obo/GO_0005643) (nuclear pore), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0070431](http://purl.obolibrary.org/obo/GO_0070431) (nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0051650](http://purl.obolibrary.org/obo/GO_0051650) (establishment of vesicle localization), [GO:0051537](http://purl.obolibrary.org/obo/GO_0051537) (2 iron, 2 sulfur cluster binding), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0032270](http://purl.obolibrary.org/obo/GO_0032270) (positive regulation of cellular protein metabolic process), [GO:0060662](http://purl.obolibrary.org/obo/GO_0060662) (salivary gland cavitation), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0060789](http://purl.obolibrary.org/obo/GO_0060789) (hair follicle placode formation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0010875](http://purl.obolibrary.org/obo/GO_0010875) (positive regulation of cholesterol efflux), [GO:0051028](http://purl.obolibrary.org/obo/GO_0051028) (mRNA transport), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:1901532](http://purl.obolibrary.org/obo/GO_1901532) (regulation of hematopoietic progenitor cell differentiation), [GO:1901533](http://purl.obolibrary.org/obo/GO_1901533) (negative regulation of hematopoietic progenitor cell differentiation), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0001782](http://purl.obolibrary.org/obo/GO_0001782) (B cell homeostasis), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0033588](http://purl.obolibrary.org/obo/GO_0033588) (Elongator holoenzyme complex), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0010888](http://purl.obolibrary.org/obo/GO_0010888) (negative regulation of lipid storage), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032495](http://purl.obolibrary.org/obo/GO_0032495) (response to muramyl dipeptide), [GO:0008385](http://purl.obolibrary.org/obo/GO_0008385) (IkappaB kinase complex), [GO:1902236](http://purl.obolibrary.org/obo/GO_1902236) (negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:0007612](http://purl.obolibrary.org/obo/GO_0007612) (learning), [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding), [GO:0042975](http://purl.obolibrary.org/obo/GO_0042975) (peroxisome proliferator activated receptor binding), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0006913](http://purl.obolibrary.org/obo/GO_0006913) (nucleocytoplasmic transport), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0071216](http://purl.obolibrary.org/obo/GO_0071216) (cellular response to biotic stimulus), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0035994](http://purl.obolibrary.org/obo/GO_0035994) (response to muscle stretch), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0034142](http://purl.obolibrary.org/obo/GO_0034142) (toll-like receptor 4 signaling pathway), [GO:0090263](http://purl.obolibrary.org/obo/GO_0090263) (positive regulation of canonical Wnt signaling pathway), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:0043276](http://purl.obolibrary.org/obo/GO_0043276) (anoikis), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0042346](http://purl.obolibrary.org/obo/GO_0042346) (positive regulation of NF-kappaB import into nucleus), [GO:0004475](http://purl.obolibrary.org/obo/GO_0004475) (mannose-1-phosphate guanylyltransferase activity), [GO:0009888](http://purl.obolibrary.org/obo/GO_0009888) (tissue development), [GO:0051059](http://purl.obolibrary.org/obo/GO_0051059) (NF-kappaB binding), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0010467](http://purl.obolibrary.org/obo/GO_0010467) (gene expression), [GO:0010745](http://purl.obolibrary.org/obo/GO_0010745) (negative regulation of macrophage derived foam cell differentiation), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0009298](http://purl.obolibrary.org/obo/GO_0009298) (GDP-mannose biosynthetic process), [GO:0061153](http://purl.obolibrary.org/obo/GO_0061153) (trachea gland development), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0042476](http://purl.obolibrary.org/obo/GO_0042476) (odontogenesis), [GO:0009058](http://purl.obolibrary.org/obo/GO_0009058) (biosynthetic process), [GO:0042994](http://purl.obolibrary.org/obo/GO_0042994) (cytoplasmic sequestering of transcription factor), [GO:0045746](http://purl.obolibrary.org/obo/GO_0045746) (negative regulation of Notch signaling pathway), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0072686](http://purl.obolibrary.org/obo/GO_0072686) (mitotic spindle), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0070427](http://purl.obolibrary.org/obo/GO_0070427) (nucleotide-binding oligomerization domain containing 1 signaling pathway), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0016779](http://purl.obolibrary.org/obo/GO_0016779) (nucleotidyltransferase activity), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0000922](http://purl.obolibrary.org/obo/GO_0000922) (spindle pole), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008139](http://purl.obolibrary.org/obo/GO_0008139) (nuclear localization sequence binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0071345](http://purl.obolibrary.org/obo/GO_0071345) (cellular response to cytokine stimulus), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 54.04%
- [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity) 52.50%
- [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding) 51.25%
- [GO:0072686](http://purl.obolibrary.org/obo/GO_0072686) (mitotic spindle) 51.25%
- [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding) 51.25%
- [GO:0051537](http://purl.obolibrary.org/obo/GO_0051537) (2 iron, 2 sulfur cluster binding) 51.25%
- [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity) 51.25%
- [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell) 51.25%
- [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding) 51.25%
- [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity) 51.25%
- [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding) 51.25%
- [GO:0033588](http://purl.obolibrary.org/obo/GO_0033588) (Elongator holoenzyme complex) 51.25%
- [GO:0008385](http://purl.obolibrary.org/obo/GO_0008385) (IkappaB kinase complex) 51.25%
- [GO:0008139](http://purl.obolibrary.org/obo/GO_0008139) (nuclear localization sequence binding) 51.25%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 51.25%


